Neurodegeneration – Products

PacBio enhances HiFi sequencing with AI-based methylation detection, enabling accurate native 5hmC and strand-specific 5mC analysis.

Amsbio has launched a new range of 96-well Deubiquitinating (DUB) enzyme assay kits for high-throughput screening. The kits are designed to measure DUB enzyme activity and screen inhibitors in cell-based models and purified enzyme systems.

AMSBIO has broadened its biofluid collection and processing capabilities, now offering a wide range of customizable human blood biospecimens.

This article introduces the role of kinases in neurodegenerative diseases, the development of kinase inhibitors for the treatment of AD, PD, and ALS, as well as the challenges in developing kinase-targeted drugs

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced another major accomplishment in its long-standing neuroscience collaboration with Bristol Myers Squibb (NYSE: BMY).

This article reviews pathological and physiological role of Tau proteins in neurodegeneration, Tau-targeted drug development strategies, and SignalChem’s contribution

bit.bio, announces the launch of its ioTracker Cells range, starting with GFP ioMicroglia, a progressive tool designed to accelerate complex neurodegenerative disease research and drug discovery.

Partnership complements Sapient’s mass spectrometry-based proteomics services, extends multi-omics solutions, and will enable development of NULISAseq™ assays under regulated guidance.

Spear Bio Inc., announced that its pTau 217 blood test has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).

Alfa Chemistry now has an extensive range of products within the pharmaceutical field, including PROTAC building blocks, nucleosides, intermediates and Active Pharmaceutical Ingredients (APIs).